The United Kingdom is witnessing a growing surge in interest surrounding copyright substances. Beyond the common use of psilocybin and LSD, investigators and enthusiasts are increasingly focused on less-charted areas, particularly the copyright compound and the nascent cannabinoid, cannabigerol.